Integrin αvβ6-targeted PET in Malignant Tumors

This study is evaluating a new type of PET scan that uses a molecule targeting a protein called integrin αvβ6 — a marker found on the surface of certain cancer cells. Researchers want to see if this specialized scan can better detect and characterize tumors (including lung cancer) compared to existing imaging methods. This is a diagnostic imaging study, not a treatment trial. **You may be eligible if...** - You are 18 or older - You have a newly confirmed malignant tumor or suspected lung cancer - You have not yet received any cancer treatment (no chemotherapy, radiation, or targeted therapy before the scan) - Your general health is good (ECOG score 0–1) **You may NOT be eligible if...** - You have a known allergy to the imaging agent - You have severe liver or kidney problems - You are claustrophobic or have a psychiatric disorder - You have had another cancer before this diagnosis - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.